IMIST


Myeloproliferative neoplasms : (notice n° 14366)

000 -LEADER
fixed length control field 01720cam a2200313' 4500
001 - CONTROL NUMBER
control field UNI0000787
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20161124094008.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140918s2011 us a b 001 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781607612650
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1607612658
040 ## - CATALOGING SOURCE
Modifying agency IMIST
Description conventions rda
040 ## - CATALOGING SOURCE
Original cataloging agency BTCTA
Description conventions rda
041 1# - LANGUAGE CODE
Language code of text/sound track or separate title eng
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC645.75
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99441
Edition number 22.
245 #0 - TITLE STATEMENT
Title Myeloproliferative neoplasms :
Remainder of title biology and therapy
Statement of responsibility, etc edited by Srdan Verstovsek, Ayalew Tefferi.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc New York
Name of publisher, distributor, etc Humana Press
Date of publication, distribution, etc c2011.
300 ## - PHYSICAL DESCRIPTION
Extent x, 228 pages
Other physical details illustrations (some color)
Dimensions 27 cm.
490 1# - SERIES STATEMENT
Series statement Contemporary hematology
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Diagnosis and classification of the BCR-ABL1-negative myeloproliferative neoplasms -- Genetics of the myeloproliferative neoplasms -- Cytogenetic findings in classical MPNs -- Prognostic factors in classic myeloproliferative neoplasms -- Therapy of polycythemia vera and essential thrombocythemia -- Conventional and investigational therapy for primary myelofibrosis -- Hematopoietic cell transplantation for myelofibrosis -- JAK2 inhibitors for therapy of myeloproliferative neoplasms -- Blastic transformation of classic myeloproliferative neoplasms -- Eosinophilic disorders: differential diagnosis and management -- Pathogenesis, diagnosis, classification, and management of systemic mastocytosis.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Myeloproliferative disorders
General subdivision Tumors.
-- therapy.
-- therapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Bone marrow
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Myelodysplastic-Myeloproliferative Diseases
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Myelodysplastic-Myeloproliferative Diseases
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Bone Marrow Neoplasms
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Verstovsek, Srdan.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tefferi, Ayalew.
Exemplaires
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
        La bibliothèque des Sciences Médicales et Pharmaceutiques La bibliothèque des Sciences Médicales et Pharmaceutiques   23277   616.994 41 VER 0000000020454 11/24/2016 11/24/2016 Livre
© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha